Edition:
United States

Resmed Inc (RMD)

RMD on New York Consolidated

106.80USD
17 Aug 2018
Change (% chg)

$-0.04 (-0.04%)
Prev Close
$106.84
Open
$107.04
Day's High
$107.24
Day's Low
$106.25
Volume
755,135
Avg. Vol
677,989
52-wk High
$109.97
52-wk Low
$72.49

Chart for

About

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD),... (more)

Overall

Beta: 0.90
Market Cap(Mil.): $15,244.46
Shares Outstanding(Mil.): 142.74
Dividend: 0.37
Yield (%): 1.39

Financials

  RMD Industry Sector
P/E (TTM): 33.87 44.74 30.45
EPS (TTM): 3.15 -- --
ROI: 16.02 7.91 12.63
ROE: 22.57 11.65 14.82

BRIEF-Infoscan Signs LoI With ResMed Polska

* REPORTED ON WEDNESDAY IT HAS SIGNED LETTER OF INTENT (LOI) WITH RESMED POLSKA ON COOPERATION

Aug 09 2018

BRIEF-Resmed Inc Q3 GAAP Earnings Per Share $0.76

* RESMED INC ANNOUNCES RESULTS FOR THE THIRD QUARTER OF FISCAL YEAR 2018

Apr 26 2018

BRIEF-Resmed Says Co Entered Certain Amended And Restated Credit Agreement, Dated As Of Closing Date

* RESMED SAYS ON APRIL 17, 2018 ('CLOSING DATE'), CO ENTERED CERTAIN AMENDED AND RESTATED CREDIT AGREEMENT, DATED AS OF CLOSING DATE - SEC FILING

Apr 19 2018

BRIEF-ResMed Hires Bobby Ghoshal As First Chief Technology Officer

* RESMED HIRES BOBBY GHOSHAL AS FIRST CHIEF TECHNOLOGY OFFICER Source text for Eikon: Further company coverage:

Apr 02 2018

Earnings vs. Estimates